Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: Immunohistochemical and double-fluorescence immunostaining evidence

Histopathology

Volumn 52, Issue 2, 2008, Pages 224-232

  Zhang, F ^a   Chen, X P ^a   Zhang, W ^a   Dong, H H ^a   Xiang, S ^a   Zhang, W G ^a   Zhang, B X ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cholangiocyte; Combined hepatocellular cholangiocarcinoma; Hepatic progenitor cells; Hepatocyte

Indexed keywords

ALPHA FETOPROTEIN; CD34 ANTIGEN; CD45 ANTIGEN; CHROMOGRANIN A; CYTOKERATIN 19; CYTOKERATIN 7; PROTEIN; PROTEIN HEPPAR1; PROTEIN OV 6; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STEM CELL;

ADULT; AGED; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CHOLANGIOCARCINOMA; FEMALE; HEPATOCYTES; HUMANS; KERATIN-19; KERATIN-7; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PAR-1; STEM CELLS;

EID: 37549021879     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02929.x     Document Type: Article

References (44)

1. Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am. J. Pathol. 1949 25 647 655.
2. Ishak KG, Anthony PP, Sobin LH. Histological typing of the liver. WHO International Histological Classification of Tumours, 2nd edn. Hong Kong : Springer-Verlag, 1994.
3. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L. Combined hepatocellular cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 1985 55 124 135.
4. Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J. Gastroenterol. Hepatol. 1996 11 758 764.
5. Libbrecht L. Hepatic progenitor cells in human liver tumor development. World J. Gastroenterol. 2006 12 6261 6265.
6. Fausto N. Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease. Semin. Liver Dis. 1999 19 243 252.
7. Sell S. The role of determined stem-cells in the cellular lineage of hepatocellular carcinoma. Int. J. Dev. Biol. 1993 37 189 201.
8. Roskams TA, Theise ND, Balabaud C et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 2004 39 1739 1745.
9. Eleazar JA, Memeo L, Jhang JS et al. Progenitor cell expansion: an important source of hepatocyte regeneration in chronic hepatitis. J. Hepatol. 2004 4l 983 991.
10. Clouston AD, Powell EE, Walsh MJ, Richardson MM, Demetris AJ, Jonsson JR. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 2005 41 809 818.
11. Roskams T, De Vos R, Desmet V. 'Undifferentiated progenitor cells' in focal nodular hyperplasia of the liver. Histopathology 1996 28 291 299.
12. Roskams TA, Libbrecht L, Desmet VJ. Progenitor cells in diseased human liver. Semin. Liver Dis. 2003 23 385 396.
13. Haruna Y, Saito K, Spaulding S, Nalesnik MA, Gerber MA. Identification of bipotential progenitor cells in human liver development. Hepatology 1996 23 476 481.
14. Evarts RP, Nagy P, Nakatsukasa H, Marsden E, Thorgeirsson SS. In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res. 1989 49 1541 1547.
15. Leong AS, Sormunen RT, Tsui WM, Liew CT. Hep Par 1 and selected antibodies in the immunohistologic distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumors and metastatic carcinoma. Histopathology 1998 33 318 324.
16. Paku S, Schnur J, Nagy P, Thorgeirsson SS. Origin and structural evolution of the early proliferating oval cells in rat liver. Am. J. Pathol. 2001 158 1313 1323.
17. Crosby HA, Hubscher SG, Joplin RE, Kelly DA, Strain AJ. Immunolocalization of OV-6, a putative progenitor cell marker in human fetal and diseased pediatric liver. Hepatology 1998 28 980 985.
18. Crosby HA, Kelly DA, Strain AJ. Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium. Gastroenterology 2001 120 534 544.
19. Bordoni V, Alonzi T, Zanetta L et al. Hepatocyte-conditioned medium sustains endothelial differentiation of human hematopoietic-endothelial progenitors. Hepatology 2007 45 1218 1228.
20. Roskams T, De Vos R, Van Eyken P, Myazaki H, Van Damme B, Desmet V. Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J. Hepatol. 1998 29 455 463.
21. Ng IO, Shek TW, Nicholls J, Ma LT. Combined hepatocellular- cholangiocarcinoma: a clinicopathological study. J. Gastroenterol. Hepatol. 1998 13 34 40.
22. Aoki K, Takayasu K, Kawano T et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology 1993 18 1090 1095.
23. Liu CL, Fan ST, Lo CM et al. Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch. Surg. 2003 138 86 90.
24. The Liver Cancer Study Group of Japan. Fourteenth National Primary Liver Cancer Tracking Survey Report (1996-1997) (in Japanese). Kyoto : Shinkou Printed, 2000.
25. Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY, Chen YF. Long-term outcome of resection of large hepatocellular carcinoma. Br. J. Surg. 2006 93 600 606.
26. Chu PG, Ishizawa S, Wu E, Weiss LM. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am. J. Surg. Pathol. 2002 26 978 988.
27. Uenishi T, Kubo S, Yamamoto T et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 2003 94 851 857.
28. Durnez A, Verslype C, Nevens F et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006 49 138 151.
29. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006 25 3818 3822.
30. Petersen BE, Bowen WC, Patrene KD et al. Bone marrow as a potential source of hepatic oval cells. Science 1999 284 1168 1170.
31. Theise ND, Nimmakayalu M, Gardner R et al. Liver from bone marrow in humans. Hepatology 2000 32 11 16.
32. Baumann U, Crosby HA, Ramani P, Kelly DA, Strain AJ. Expression of stem cell receptor c-kit in normal and diseased pediatric liver. Hepatology 1999 30 112 117.
33. Thorgeirsson SS, Grisham JW. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology 2006 43 2 8.
34. Ernst SI, Hubbs AE, Przygodzki RM, Emory TS, Sobin LH, O'Leary TJ. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab. Invest. 1998 78 1633 1636.
35. zTonary AM, Macdonald EA, Faught W, Senterman MK, Vanderhyden BC. Lack of expression of c-KIT in ovarian cancers is associated with poor prognosis. Int. J. Cancer 2000 89 242 250.
36. Ramadori G, Fuzesi L, Grabbe E, Pieler T, Armbrust T. Successful treatment of hepatocellular carcinoma with the tyrosine kinase inhibitor imatinib in a patient with liver cirrhosis. Anticancer Drugs 2004 15 405 409.
37. Libbrecht L, De Vos R, Cassiman D, Desmet V, Aerts R, Roskams T. Hepatic progenitor cells in hepatocellular adenomas. Am. J. Surg. Pathol. 2001 25 1388 1396.
38. Libbrecht L, Desmet V, Van Damme B, Roskams T. The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J. Hepatol. 2000 33 76 84.
39. Van Den Heuvel MC, Slooff MJ, Visser L et al. Expression of anti-OV6 antibody and anti-N-CAM antibody along the biliary line of normal and diseased human livers. Hepatology 2001 33 1387 1393.
40. Alison MR. Characterization of the differentiation capacity of rat-derived hepatic stem cells. Semin. Liver Dis. 2003 23 325 336.
41. Tanaka S, Hirohashi K, Uenishi T et al. A mixed hepatocellular carcinoma and cholangiocarcinoma: dual expression of biliary-type cytokeratin and hepatocyte specific marker. Hepatogastroenterology 2004 51 839 841.
42. Yano H, Iemura A, Haramaki M et al. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions. J. Hepatol. 1996 24 413 422.
43. Wiemann SU, Satyanarayan A, Tsahuridu M et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J. 2002 16 935 942.
44. Wiemann SU, Satyanarayan A, Buer J, Kamino K, Manns MP, Rudolph KL. Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage. Oncogene 2005 249 1501 1509.